We begin by discussing genetic, developmental, and environmental determinants of epigenetic state in human and model systems, then describe some of the diverse data implicating epigenetic mechanisms in various human diseases, both within individuals and across generations.
An overview of the research you will conduct at Harvard: My role in the entire research interests of Philippe Cluzel's group is to extend the principal idea of optimization of gene/protein expression levels in eukaryotic system, starting with yeast as model system and then extending further to plant/ mammalian system based on the progress/ success.
The most straightforward way to study phase behavior by computer simulation is to change the temperature or pressure of a given model system and then to simply wait for a phase transformation to occur.
This could be tested using our model system and then, if successful, tried in a clinical setting.
We heat-shocked the progeny at the adult emergence stage in our model system and then analyzed the time course of the resulting fluorescence (Figure 4).
Thus, this study stands as the first example of a disease phenotype being initially discovered in an hPSC-based model system and then subsequently confirmed in patients.
The typical approach involves the introduction of sequences of evolutionary interest into a model system, and then searching for spatial or temporal differences in gene expression that can be ascribed to the introduced sequence (Enard et al., 2009; Cotney et al., 2013).
In this regard, it is common to apply the suitable simulation optimization technique to model the system then determine the required operation parameters.
The model-based system then expresses three signed SPEs and three unsigned SPEs in response to the outcome.
Ultimately, systems vaccinology is an iterative approach in which mechanistic hypotheses derived from analysis of clinical studies are evaluated in model systems, and then used to guide the development of new vaccine strategies.
